About Amphera
Amphera is a company based in 's-hertogenbosch (Netherlands) founded in 2012.. Amphera offers products and services including MesoPher. Amphera operates in a competitive market with competitors including TScan Therapeutics, GigaGen, Shattuck Labs, Boundless Bio and Bolt Biotherapeutics, among others.
- Headquarter 's-hertogenbosch, Netherlands
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Amphera B.V.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$52.13 K (USD), Grant
Jan 01, 2016
-
Investors
European Union
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Amphera
Amphera offers a comprehensive portfolio of products and services, including MesoPher. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Autologous dendritic cell therapy for treating mesothelioma and pancreatic cancer.
Funding Insights of Amphera
- Total Funding Total Funding
- Total Rounds 3
- Last Round Grant — $52,128
- First Round First Round
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2016 | Amount | Grant - Amphera | Valuation |
investors |
|
| Mar, 2014 | Amount | Debt – Conventional - Amphera | Valuation |
investors |
|
| Mar, 2014 | Amount | Seed - Amphera | Valuation | Brabant Life Sciences Seed Fund |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Amphera
Amphera has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, RedMedTech Discovery Fund and Brabant Life Sciences Seed Fonds. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Funding is provided for innovations in medical technology startups.
|
Founded Year | Domain | Location | |
|
Seed funding is offered for life sciences startups.
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Amphera
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Amphera
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Amphera Comparisons
Competitors of Amphera
Amphera operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TScan Therapeutics, GigaGen, Shattuck Labs, Boundless Bio and Bolt Biotherapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
T cell-based treatments for immunological and oncological disorders are developed.
|
|
| domain | founded_year | HQ Location |
T-cell and antibody-based therapeutics are developed via single-cell sequencing platforms.
|
|
| domain | founded_year | HQ Location |
An immunotherapy platform for oncology and other diseases is developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer are developed by targeting ecDNA.
|
|
| domain | founded_year | HQ Location |
T-cell therapies for cancer treatment are developed by Bolt Biotherapeutics.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Amphera
Frequently Asked Questions about Amphera
When was Amphera founded?
Amphera was founded in 2012 and raised its 1st funding round 2 years after it was founded.
Where is Amphera located?
Amphera is headquartered in 's-hertogenbosch, Netherlands. It is registered at 's-hertogenbosch, Noord-brabant, Netherlands.
Who is the current CEO of Amphera?
Rob Meijer is the current CEO of Amphera.
What does Amphera do?
Amphera was founded in 2012 and is engaged in the biotechnology sector, where dendritic cell immunotherapies are developed for malignant mesothelioma and additional cancers. The lead candidate, MesoPher, is formulated using mesothelioma tumor cells instructed with a lysate. Operations focus on advancing these treatments through research and clinical development, with activities based in the Netherlands.
Who are the top competitors of Amphera?
Amphera's top competitors include Lyell Immunopharma, GigaGen and Shattuck Labs.
What products or services does Amphera offer?
Amphera offers MesoPher.
Who are Amphera's investors?
Amphera has 3 investors. Key investors include European Union, RedMedTech Discovery Fund, and Brabant Life Sciences Seed Fonds.